 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
1yz5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
4 terms
|
 |
|
Biological process
|
cell proliferation
|
15 terms
|
 |
|
Biochemical function
|
protein binding
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell Res
15:219-227
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization.
|
|
A.Benzinger,
G.M.Popowicz,
J.K.Joy,
S.Majumdar,
T.A.Holak,
H.Hermeking.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Seven different, but highly conserved 14-3-3 proteins are involved in diverse
signaling pathways in human cells. It is unclear how the 14-3-3sigma isoform, a
transcriptional target of p53, exerts its inhibitory effect on the cell cycle in
the presence of other 14-3-3 isoforms, which are constitutively expressed at
high levels. In order to identify structural differences between the 14-3-3
isoforms, we solved the crystal structure of the human 14-3-3sigma protein at a
resolution of 2.8 Angstroms and compared it to the known structures of
14-3-3zeta and 14-3-3tau. The global architecture of the 14-3-3sigma fold is
similar to the previously determined structures of 14-3-3zeta and 14-3-3t: two
14-3-3sigma molecules form a cup-shaped dimer. Significant differences between
these 14-3-3 isoforms were detected adjacent to the amphipathic groove, which
mediates the binding to phosphorylated consensus motifs in 14-3-3-ligands.
Another specificity determining region is localized between amino-acids 203 to
215. These differences presumably select for the interaction with specific
ligands, which may explain the different biological functions of the respective
14-3-3 isoforms. Furthermore, the two 14-3-3sigma molecules forming a dimer
differ by the spatial position of the ninth helix, which is shifted to the
inside of the ligand interaction surface, thus indicating adaptability of this
part of the molecule. In addition, 5 non-conserved residues are located at the
interface between two 14-3-3sigma proteins forming a dimer and represent
candidate determinants of homo- and hetero-dimerization specificity. The
structural differences among the 14-3-3 isoforms described here presumably
contribute to isoform-specific interactions and functions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
An overall ribbon plot of the 14-3-3 homodimer.
Each monomer consists of nine antiparallel helices and the
protein dimerizes in a perfect 2-fold symmetry. The dimer forms
a large cup-shaped space between monomers with two
phosphopeptide binding sites at its sides. The C-terminal helix
of the monomer A (blue) is significantly shifted toward the
binding site; chain B is shown in dark-red. (A) a view
perpendicular to the helices axis is presented. (B) a view
parallel to this axis.
|
 |
Figure 5.
Ligand recognition by 14-3-3 proteins. (A) Unbound (red)
and (blue)
are superimposed with the structure of the isoform
(green) bound to serotonin N-acetyltransferase (C trace)
to indicate the structural diversity of the Ala203 and Asp215
loop area. (B) Structures of (blue)
and (red)
are overlaid. The molecular surface of the isoform
is shown half-transparent. The structure and surface of the
phosphopeptide from the 1QJA model is shown in light blue.
Non-conserved residues in this area are labeled for the isoform.
Significant difference in the Ala203 and Asp215 loop are evident.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Cell Res
(2005,
15,
219-227)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Yasmin,
J.L.Veesenmeyer,
M.H.Diaz,
M.S.Francis,
C.Ottmann,
R.H.Palmer,
A.R.Hauser,
and
B.Hallberg
(2010).
Electrostatic interactions play a minor role in the binding of ExoS to 14-3-3 proteins.
|
| |
Biochem J, 427,
217-224.
|
 |
|
|
|
|
 |
K.Kligys,
J.Yao,
D.Yu,
and
J.C.Jones
(2009).
14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytes.
|
| |
Biochem Biophys Res Commun, 383,
450-454.
|
 |
|
|
|
|
 |
M.Zannis-Hadjopoulos,
W.Yahyaoui,
and
M.Callejo
(2008).
14-3-3 cruciform-binding proteins as regulators of eukaryotic DNA replication.
|
| |
Trends Biochem Sci, 33,
44-50.
|
 |
|
|
|
|
 |
X.Liang,
M.B.Butterworth,
K.W.Peters,
W.H.Walker,
and
R.A.Frizzell
(2008).
An Obligatory Heterodimer of 14-3-3{beta} and 14-3-3{epsilon} Is Required for Aldosterone Regulation of the Epithelial Sodium Channel.
|
| |
J Biol Chem, 283,
27418-27425.
|
 |
|
|
|
|
 |
O.Gileadi,
S.Knapp,
W.H.Lee,
B.D.Marsden,
S.Müller,
F.H.Niesen,
K.L.Kavanagh,
L.J.Ball,
F.von Delft,
D.A.Doyle,
U.C.Oppermann,
and
M.Sundström
(2007).
The scientific impact of the Structural Genomics Consortium: a protein family and ligand-centered approach to medically-relevant human proteins.
|
| |
J Struct Funct Genomics, 8,
107-119.
|
 |
|
|
|
|
 |
S.N.Quayle,
and
M.D.Sadar
(2007).
14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens.
|
| |
Cancer Lett, 254,
137-145.
|
 |
|
|
|
|
 |
A.Aitken
(2006).
14-3-3 proteins: a historic overview.
|
| |
Semin Cancer Biol, 16,
162-172.
|
 |
|
|
|
|
 |
A.K.Gardino,
S.J.Smerdon,
and
M.B.Yaffe
(2006).
Structural determinants of 14-3-3 binding specificities and regulation of subcellular localization of 14-3-3-ligand complexes: a comparison of the X-ray crystal structures of all human 14-3-3 isoforms.
|
| |
Semin Cancer Biol, 16,
173-182.
|
 |
|
|
|
|
 |
D.Lodygin,
and
H.Hermeking
(2006).
Epigenetic silencing of 14-3-3sigma in cancer.
|
| |
Semin Cancer Biol, 16,
214-224.
|
 |
|
|
|
|
 |
H.Hermeking,
and
A.Benzinger
(2006).
14-3-3 proteins in cell cycle regulation.
|
| |
Semin Cancer Biol, 16,
183-192.
|
 |
|
|
|
|
 |
J.M.Lau,
C.Wu,
and
A.J.Muslin
(2006).
Differential role of 14-3-3 family members in Xenopus development.
|
| |
Dev Dyn, 235,
1761-1776.
|
 |
|
|
|
|
 |
M.H.Lee,
and
G.Lozano
(2006).
Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
|
| |
Semin Cancer Biol, 16,
225-234.
|
 |
|
|
|
|
 |
M.Lalle,
A.M.Salzano,
M.Crescenzi,
and
E.Pozio
(2006).
The Giardia duodenalis 14-3-3 protein is post-translationally modified by phosphorylation and polyglycylation of the C-terminal tail.
|
| |
J Biol Chem, 281,
5137-5148.
|
 |
|
|
|
|
 |
X.Yang,
W.H.Lee,
F.Sobott,
E.Papagrigoriou,
C.V.Robinson,
J.G.Grossmann,
M.Sundström,
D.A.Doyle,
and
J.M.Elkins
(2006).
Structural basis for protein-protein interactions in the 14-3-3 protein family.
|
| |
Proc Natl Acad Sci U S A, 103,
17237-17242.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Jin,
M.S.Dai,
S.Z.Lu,
Y.Xu,
Z.Luo,
Y.Zhao,
and
H.Lu
(2006).
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.
|
| |
EMBO J, 25,
1207-1218.
|
 |
|
|
|
|
 |
D.Lodygin,
and
H.Hermeking
(2005).
The role of epigenetic inactivation of 14-3-3sigma in human cancer.
|
| |
Cell Res, 15,
237-246.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|